Report

Kinarus - Phase II COVID-19 outpatient study underway

Kinarus has announced that it has dosed the first patient in its Phase II KINFAST study evaluating lead candidate KIN001 in mild or moderate COVID-19 patients in an outpatient setting. KINFAST is a placebo-controlled study that is designed to recruit c 400 patients across multiple sites in Switzerland and Germany. Interim data are expected after the enrolment of c 140 patients, which we anticipate should help guide KIN001’s future development as a potential treatment for COVID-19.
Underlying
Perfect Holding S.A.

Perfect Holding SA. Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The Company operates under four business divisions: optical disc, aircraft management, charters and brokerage. Perfect Holding SA, through its subsidiaries, is dedicated to the provision of services to the business aircraft market such as aircraft management, aircraft sales, charter sales and travel services. The Company manages medium- to large-business aircrafts, such as Bombardier Global and Challenger jets. The Company wholly owns three subsidiaries, including Perfect Aviation SA, based in Switzerland, Perfect Aviation Portugal SA, based in Portugal and Perfect Aviation UK Ltd, based in the United Kingdom.

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Analysts
Sean Conroy

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch